AstraZeneca India: For youth empowerment
AstraZeneca India, established in 1979 and head-quartered at Bengaluru, Karnataka believes in improving health which is one of the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
In a sweet spot
No other industry touches a billion lives as much as pharmaceuticals, with a potential to improve health outcomes of people…
Ashland increases price of hydroxyethylcellulose
Ashland Speciality Ingredients, a commercial unit of Ashland is increasing the price of its portfolio of hydroxyethylcellulose…
Elder Pharmaceuticals plans to create super brand
Self-owned brands to get a major boost especially in the fields of anti-infectives, lifestyle diseases, dermatology and neurology…
CSR: An opportunity for pharma companies
Adarsh Kataruka, Director, SoulAce Social Venture, talks about why each company needs to chart a CSR vision and work towards…
Budget 2014: Will implementation live up to intent?
I had ended my last edit with the hope that this year, unlike previous years, the pharmaceutical sector’s hopes would not be as…
‘India is crucial to us for the future’
With a 5.7 per cent growth in sales in 2013, Boehringer Ingelheim (BI) ranks seventh among its global peers but has a long way to…
Cipla plans investment in its UK subsidiary
The investment will fund the launch of a range of drugs in the areas of respiratory, oncology and antiretroviral medicines
Actavis completes acquisition of Forest Laboratories
Creates an innovative new model in speciality pharma leadership
Merck Serono’s grants programme to fund scientific innovation
The programme combines grants portfolio with annual €20 million investment to advance innovation and medical education